US3864366A
(en)
*
|
1971-12-29 |
1975-02-04 |
Eastman Kodak Co |
Novel acylamidophenol photographic couplers
|
GB1484413A
(en)
*
|
1974-04-18 |
1977-09-01 |
Kissei Pharmaceutical |
Aromatic amidocarboxylic acid derivatives
|
DE2500157C2
(de)
*
|
1975-01-03 |
1983-09-15 |
Hoechst Ag, 6230 Frankfurt |
N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
|
US4042711A
(en)
*
|
1975-01-09 |
1977-08-16 |
Boehringer Ingelheim Gmbh |
Derivatives of biphenyloxy-lower alkanoic acids, salts thereof and their use as antihyperlipidemics
|
AT341512B
(de)
*
|
1975-01-09 |
1978-02-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung von neuen biphenylathern
|
DE2517229A1
(de)
*
|
1975-04-18 |
1976-10-28 |
Boehringer Mannheim Gmbh |
Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
|
DE2532420A1
(de)
*
|
1975-07-19 |
1977-02-03 |
Boehringer Mannheim Gmbh |
Phenylessigsaeure-derivate und verfahren zu ihrer herstellung
|
DE2541342A1
(de)
*
|
1975-09-17 |
1977-03-31 |
Boehringer Mannheim Gmbh |
Neue phenoxyalkylcarbonsaeuren und verfahren zur herstellung derselben
|
DE2546996C2
(de)
*
|
1975-10-21 |
1984-07-05 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Phenoxyalkylcarbonsäure-Derivate, Verfahren zur Herstellung derselben sowie Arzneimittel, die diese Verbindungen als Wirkstoff enthalten
|
US4214094A
(en)
*
|
1977-03-30 |
1980-07-22 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted-phenyl substituted-alkyl ethers and the preparation thereof
|
JPS5649906B2
(en)
*
|
1978-05-12 |
1981-11-25 |
Boehringer Mannheim Gmbh |
Manufacture of alphaa*44*44chlorobenzoylaminoo ethyl**phenoxy**isoethylacetic acid
|
JPS56145261A
(en)
*
|
1980-04-10 |
1981-11-11 |
Kaken Pharmaceut Co Ltd |
Novel oxyacetic acid derivative, its preparation, and lowering agent of lipid in blood comprising it as active ingredient
|
US4281190A
(en)
*
|
1980-08-14 |
1981-07-28 |
Morton-Norwich Products, Inc. |
Process for preparing N-[2-(p-hydroxyphenyl)-ethyl]-p-chlorobenzamide
|
JPS57140754A
(en)
*
|
1981-02-24 |
1982-08-31 |
Kureha Chem Ind Co Ltd |
Dihydroxybenzoic acid derivative and physiologically active preparation containing the same
|
US4927955A
(en)
*
|
1987-08-12 |
1990-05-22 |
Sanofi |
Process for the O-alkylation of N-(hydroxy)aralkylphenylethanolamines
|
IL102707A
(en)
*
|
1992-08-02 |
1996-11-14 |
Cherkez Stephen |
Processes for the preparation of tyramine derivatives
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6083497A
(en)
|
1997-11-05 |
2000-07-04 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
|
NZ512535A
(en)
|
1998-12-23 |
2003-12-19 |
G |
Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
|
EP1340508A1
(en)
|
1998-12-23 |
2003-09-03 |
G.D. Searle LLC. |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
|
JP2002533412A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー.ディー.サール エルエルシー |
心臓血管に適用するための回腸胆汁酸輸送阻害剤およびコレステリルエステル転送タンパク質阻害剤の組み合わせ
|
AU2157400A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle & Co. |
Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
|
CN1338944A
(zh)
*
|
1998-12-23 |
2002-03-06 |
G.D.瑟尔有限公司 |
用于心血管适应症的胆固醇酯转移蛋白抑制剂和苯氧异丁酸类衍生物的联合形式
|
ES2207330T3
(es)
*
|
1998-12-23 |
2004-05-16 |
G.D. Searle Llc |
Combinaciones de un inhibidor de ibat y de un inhibidor de mtp para indicaciones cardiovasculares.
|
PT1140189E
(pt)
*
|
1998-12-23 |
2003-09-30 |
Searle Llc |
Combinacoes de inibidores do transporte do acido biliar ileal e de derivados do acido fibrico para indicacoes cardiovasculares
|
ES2203239T3
(es)
|
1998-12-23 |
2004-04-01 |
G.D. Searle Llc |
Combinaciones de inhibidores de la proteina de transferencia de ester de colesterilo y de agentes secuestrantes de acidos biliares para indicaciones cardiovasculares.
|
WO2001051454A1
(en)
*
|
2000-01-13 |
2001-07-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US20020061888A1
(en)
*
|
2000-03-10 |
2002-05-23 |
Keller Bradley T. |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
JP2003528830A
(ja)
|
2000-03-10 |
2003-09-30 |
ファルマシア・コーポレーション |
テトラヒドロベンゾチエピン類の製造方法
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
EP1911462A3
(en)
|
2001-01-26 |
2011-11-30 |
Schering Corporation |
Compositions comprising a sterol absorption inhibitor
|
BR0206644A
(pt)
*
|
2001-01-26 |
2004-02-25 |
Schering Corp |
Combinações de inibidor(es) de absorção de esteróis com agente(s) cardiovascular(es) para o tratamento de condições vasculares
|
US7071181B2
(en)
*
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
ES2274013T3
(es)
*
|
2001-01-26 |
2007-05-16 |
Schering Corporation |
Combinaciones de activador(es) del receptor activado por el proliferador de los peroxisomas (ppar) e inhibidor(es)m de la absorcion de estelores y tratamientos para trastornos vasculares.
|
ES2287250T3
(es)
*
|
2001-01-26 |
2007-12-16 |
Schering Corporation |
Combinaciones de secuestrante(s) de acidos biliares e inhibidor(es) de la absorcion de esteroles y tratamientos para indicaciones vasculares.
|
AR032403A1
(es)
*
|
2001-01-26 |
2003-11-05 |
Schering Corp |
Combinaciones de inhibidor(es) de la absorcion de esterol con modificador(es) sanguineos para tratar cuadros vasculares
|
RS50406B
(sr)
*
|
2001-01-26 |
2009-12-31 |
Schering Corporation, |
Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
|
CA2434488A1
(en)
*
|
2001-01-26 |
2002-08-01 |
Harry R. Davis |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
|
PT1392287E
(pt)
*
|
2001-05-25 |
2007-02-28 |
Schering Corp |
Métodos para tratamento de doença de alzheimer e/ou regulação dos níveis de peptídeos β amilóide num sujeito
|
US20040077625A1
(en)
*
|
2001-07-25 |
2004-04-22 |
Tremont Samuel J. |
Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake
|
DK1427409T3
(da)
*
|
2001-09-21 |
2009-01-12 |
Schering Corp |
Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer
|
EP1429756B1
(en)
*
|
2001-09-21 |
2006-11-22 |
Schering Corporation |
Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
US20030119808A1
(en)
*
|
2001-09-21 |
2003-06-26 |
Schering Corporation |
Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
|
US7056906B2
(en)
*
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
WO2003040127A1
(en)
*
|
2001-11-02 |
2003-05-15 |
G.D. Searle Llc |
Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
|
MXPA04006255A
(es)
|
2002-01-17 |
2004-09-27 |
Pharmacia Corp |
Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
|
EP1560579A1
(en)
*
|
2002-11-06 |
2005-08-10 |
Schering Corporation |
Cholesterol absorption inhibitors for the treatment of autoimmune disorders
|
JP2006519869A
(ja)
*
|
2003-03-07 |
2006-08-31 |
シェーリング コーポレイション |
置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
|
US7459442B2
(en)
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
ES2311806T3
(es)
|
2003-03-07 |
2009-02-16 |
Schering Corporation |
Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
CN1756756A
(zh)
|
2003-03-07 |
2006-04-05 |
先灵公司 |
取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
JP4901474B2
(ja)
|
2003-05-30 |
2012-03-21 |
ランバクシー ラボラトリーズ リミテッド |
置換ピロール誘導体
|
US7601756B2
(en)
*
|
2003-06-06 |
2009-10-13 |
Snowden Pharmaceuticals, Llc |
Method of treatment for irritable bowel syndrome
|
WO2005046797A2
(en)
*
|
2003-11-05 |
2005-05-26 |
Schering Corporation |
Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
|
WO2007054896A1
(en)
|
2005-11-08 |
2007-05-18 |
Ranbaxy Laboratories Limited |
Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
FR2898892A1
(fr)
*
|
2006-03-24 |
2007-09-28 |
Genfit Sa |
Derives de n-(phenethyl)benzamide substitues,preparation et utilisations
|
FR2898894B1
(fr)
*
|
2006-03-24 |
2008-06-06 |
Genfit Sa |
Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
|
US20100210633A1
(en)
*
|
2006-10-12 |
2010-08-19 |
Epix Delaware, Inc. |
Carboxamide compounds and their use
|
TW200901959A
(en)
|
2007-03-09 |
2009-01-16 |
Indigene Pharmaceuticals Inc |
Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
|
WO2009076404A1
(en)
*
|
2007-12-10 |
2009-06-18 |
Epix Delaware, Inc. |
Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
|
BRPI0820701A2
(pt)
|
2007-12-11 |
2015-06-16 |
Cytopathfinder Inc |
Composto de carboxamida e seu uso como agonistas do receptor de quimiocina
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
MX2017010131A
(es)
|
2015-02-06 |
2017-11-01 |
Intercept Pharmaceuticals Inc |
Composiciones farmaceuticas para terapia combinada.
|
CN111343976A
(zh)
|
2017-11-15 |
2020-06-26 |
日本化学药品株式会社 |
过氧化物酶体增殖物应答性受体活化剂
|
BR112021024109A2
(pt)
|
2019-05-30 |
2022-03-22 |
Intercept Pharmaceuticals Inc |
Composições farmacêuticas compreendendo um agonista fxr e um fibrato para uso no tratamento de doença hepática colestática
|